Tenaya Therapeutics (TNYA)
(Delayed Data from NSDQ)
$4.40 USD
+0.12 (2.80%)
Updated May 14, 2024 04:00 PM ET
After-Market: $4.40 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Cash flow Statements
Fiscal Year End for Tenaya Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -124.08 | -123.67 | -72.72 | -38.40 | 0.00 |
Depreciation/Amortization & Depletion | 9.00 | 6.16 | 2.96 | 2.48 | 0.00 |
Net Change from Assets/Liabilities | -5.65 | -0.85 | 4.74 | -0.23 | 0.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 18.66 | 13.93 | 4.21 | 0.70 | 0.00 |
Net Cash From Operating Activities | -102.07 | -104.42 | -60.81 | -35.45 | 0.00 |
Property & Equipment | -1.24 | -20.63 | -25.12 | -9.76 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 49.98 | 104.27 | -213.44 | 2.75 | 0.00 |
Other Investing Activities | -0.03 | 0.01 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 48.72 | 83.65 | -238.56 | -7.01 | 0.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.55 | 77.77 | 208.88 | 147.27 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.09 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.50 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 4.05 | 77.77 | 208.97 | 147.27 | 0.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -49.31 | 57.00 | -90.41 | 104.81 | 0.00 |
Cash at Beginning of Period | 95.67 | 38.68 | 129.08 | 24.27 | 0.00 |
Cash at End of Period | 46.36 | 95.67 | 38.68 | 129.08 | 0.00 |
Diluted Net EPS | -1.68 | -2.76 | -4.10 | -39.50 | NA |
Fiscal Year End for Tenaya Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -124.08 | -94.15 | -65.01 | -31.74 |
Depreciation/Amortization & Depletion | NA | 9.00 | 5.14 | 3.27 | 1.56 |
Net Change from Assets/Liabilities | NA | -5.65 | -4.98 | -3.75 | -4.44 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 18.66 | 13.84 | 8.98 | 4.32 |
Net Cash From Operating Activities | NA | -102.07 | -80.15 | -56.51 | -30.29 |
Property & Equipment | NA | -1.24 | -0.85 | -0.84 | -0.63 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 49.98 | 64.49 | 33.99 | 8.70 |
Other Investing Activities | NA | -0.03 | -0.01 | 0.00 | -0.01 |
Net Cash from Investing Activities | NA | 48.72 | 63.63 | 33.15 | 8.06 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 4.55 | 4.18 | 4.18 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.50 | -0.50 | -0.50 | -0.50 |
Net Cash from Financing Activities | NA | 4.05 | 3.68 | 3.68 | -0.50 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -49.31 | -12.84 | -19.69 | -22.73 |
Cash at Beginning of Period | NA | 95.67 | 95.67 | 95.67 | 95.67 |
Cash at End of Period | NA | 46.36 | 82.84 | 75.99 | 72.94 |
Diluted Net EPS | NA | -0.41 | -0.39 | -0.45 | -0.43 |